Latest Tissue plasminogen activator Stories
WINFIELD, Ill., Oct. 12 /PRNewswire-USNewswire/ -- Central DuPage Hospital (http://www.cdh.org) (CDH), in Winfield, Ill., is the only Illinois hospital that will participate in a national investigational trial to test the effectiveness of a device that might extend the traditional stroke treatment window from three hours to an unprecedented 24 hours. CDH is one of only six hospitals in the U.S. making the research trial available to acute ischemic stroke patients. The investigational device...
WALTHAM, Mass., Sept. 2 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the emerging market for neurovascular embolectomy devices for the treatment of acute ischemic stroke is poised for healthy yet conservative growth of close to 15% annually in Europe over the next 5 years. MRG's European Markets for Clot Management Devices 2009 report finds that although clinical safety data available to date has been positive...
A committee of medical experts has extended the treatment window for a stroke from three hours to 4 1/2 hours after symptoms arise.When a person begins showing signs of a stroke "“ numbness or weakness in the face, arm or leg; trouble speaking, seeing or walking; a sudden headache "“ timing is crucial. The sooner they seek medical help, the more likely they are to recover without substantial brain damage.The initial window for treatment using clot-busting drugs in stroke patients was once...
MOUNTAIN VIEW, Calif., May 14 /PRNewswire/ -- Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced the enrollment of the 500th patient in its Merci Registry, a real-world, international, post-market study of its innovative product, the Merci Retrieval System(TM). The Registry has enrolled patients from over 30 sites worldwide and is continuing to enroll patients. The Registry is the largest repository of data on mechanical intervention in acute...
Gender differences in symptoms may contribute to delay in treatment for women, signal need to change stroke public health campaigns ANN ARBOR, Mich., May 4 /PRNewswire-USNewswire/ -- The traditional stroke symptoms are well known and include a sudden onset of numbness or weakness on one side of the body, trouble talking, loss of vision, or coordination problems. But in women, doctors and bystanders should be paying attention to something else, says Lynda Lisabeth, Ph.D., MPH, researcher...
Giving clot-busting drugs to patients who wake up with stroke symptoms appears to be as safe as giving it to those in the recommended three-hour window, according to researchers at The University of Texas Medical School at Houston.The results of the study, "Thrombolytic Therapy for Patients Who Wake Up With Stroke," are published in the March issue of Stroke, a journal of the American Heart Association."The results of our study serve as the only published material of patients...
SPRINGFIELD, Mass., March 4 /PRNewswire/ -- MassMutual's Retirement Services Division is pleased to announce that Tony Carucci has joined its TPA service team as a relationship manager for the Midwest region. His role is to assist advisors with plan reviews, investment change processing, product and service education and other valuable support for TPA-serviced plans on MassMutual's platform. Mr. Carucci joined MassMutual on February 17 from Fidelity Investments. "Tony Carucci is a...
Women are 30 percent less likely than men to get stroke care that limits brain damage, U.S. researchers have found. Specifically, women are less likely to be treated with tissue plasminogen activator, known as tPA, a potent blood thinner used to dissolve the clots which cause most strokes. The finding, the result of analyzing 18 studies involving a total of 2.3 million patients, was presented by Michigan State University, East Lansing, researcher Archit Bhatt at the International Stroke...
U.S. researchers say women are 30 percent less likely than men to get stroke care that limits brain damage. Specifically, women are less likely to be treated with tissue plasminogen activator, known as tPA -- a potent blood thinner used to dissolve the clots which cause most strokes. The finding, the result of analyzing 18 studies with a total of 2.3 million patients, was presented by Michigan State University, East Lansing, researcher, Archit Bhatt at the International Stroke conference...
Patients who get an experimental clot-busting treatment for a particularly lethal form of stroke improve their chances of survival, U.S. researchers said. Study leader Dr. Daniel Hanley of the Johns Hopkins School of Medicine and colleagues reported early findings among 52 intracranial hemorrhage patients treated with the drug tissue plasminogen activator, given by catheter directly into patients' brains to bathe and destroy blood clots. The researchers worked with patients at 38 study sites...
